Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Ghossein

Showing results (111-120 of 142) with videos related to

Pageof 15
Sort By:
Annals of Surgical Oncology|June 7, 2024
Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET FusionsDaniel W Scholfield, Conall W R Fitzgerald, Lillian A Boe, et al.
Cancer Research|October 5, 2006
Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomasInderpal Sarkaria, Pornchai O-charoenrat, Simon G Talbot, et al.
Cancer Research|June 3, 2004
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic markerVolkert B Wreesmann, Elizabeth M Sieczka, Nicholas D Socci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2017
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor VirulenceTihana Ibrahimpasic, Bin Xu, Iñigo Landa, et al.
The Journal of Clinical Investigation|February 16, 2016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancersIñigo Landa, Tihana Ibrahimpasic, Laura Boucai, et al.
Molecular Cancer Research : MCR|October 12, 2021
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor TherapyMark Lee, Brian R Untch, Bin Xu, et al.
BMC Cancer|January 14, 2009
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysisCherry L Estilo, Pornchai O-charoenrat, Simon Talbot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2024
A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for In Vivo Assessment in Oral CancerDaniella K Zanoni, Paula Demétrio De Souza França, Cristina Valero, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2025
Hyalinizing Clear Cell Carcinoma of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading SchemeBin Xu, Kartik Viswanathan, Marie Barbesier, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitorsVera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
Pageof 15

Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
Annals of Surgical Oncology|June 7, 2024
Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET FusionsDaniel W Scholfield, Conall W R Fitzgerald, Lillian A Boe, et al.
Cancer Research|October 5, 2006
Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomasInderpal Sarkaria, Pornchai O-charoenrat, Simon G Talbot, et al.
Cancer Research|June 3, 2004
Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic markerVolkert B Wreesmann, Elizabeth M Sieczka, Nicholas D Socci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 22, 2017
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor VirulenceTihana Ibrahimpasic, Bin Xu, Iñigo Landa, et al.
The Journal of Clinical Investigation|February 16, 2016
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancersIñigo Landa, Tihana Ibrahimpasic, Laura Boucai, et al.
Molecular Cancer Research : MCR|October 12, 2021
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor TherapyMark Lee, Brian R Untch, Bin Xu, et al.
BMC Cancer|January 14, 2009
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysisCherry L Estilo, Pornchai O-charoenrat, Simon Talbot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2024
A Prospective Double-Blinded Comparison of Reflectance Confocal Microscopy with Conventional Histopathology for In Vivo Assessment in Oral CancerDaniella K Zanoni, Paula Demétrio De Souza França, Cristina Valero, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 5, 2025
Hyalinizing Clear Cell Carcinoma of the Head and Neck: A Multicenter Retrospective Study of 87 Cases Focusing on Prognostic Pathologic Features and Grading SchemeBin Xu, Kartik Viswanathan, Marie Barbesier, et al.
Biorxiv : the Preprint Server for Biology|March 17, 2025
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitorsVera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
Pageof 15